Atlas Trials

A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome

Clinical trial NCT00932100 · COMPLETED

Trial details

NCT number
NCT00932100
Sponsor
Regado Biosciences, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Coronary Syndrome (ACS)
Start date
2009-07-01
Primary completion
2011-01-01
Enrollment
640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.